Ss Innovations International revenue was $42.48M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $14.5M, up 13.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SSII annual revenue was $42.5M, with 105.7% growth year-over-year.
SSII past revenue growth
How has SSII's revenue growth performed historically?
On Invalid Date, Ss Innovations International (NASDAQ: SSII) reported Q4 2025 revenue of $14.53 million up 158.45% year over year. In the same quarter last year, Ss Innovations International's revenue was $5.62 million.
What was Ss Innovations International's revenue in 2025?
Ss Innovations International's annual revenue for the twelve months ending Dec 31, 2025 was $42.48 million, a 105.74% increase year over year.
How much does Ss Innovations International make in a day?
Based on Ss Innovations International annual revenue for the past four years, SSII makes an average of $48,250.50 per day.
What was Ss Innovations International's annual revenue growth in the past year?
As of Q1 2026, Ss Innovations International's revenue has grown 105.74% year over year. This is 94.97 percentage points higher than the US Medical Devices industry revenue growth rate of 10.78%. Ss Innovations International's revenue in the past year totaled $42.48 million.
How much does Ss Innovations International make in a year?
Ss Innovations International's revenue by year for the past four years is:
Ss Innovations International's revenue for the twelve months ending Dec 31, 2025 was $42.48 million, a 105.74% increase year over year.
Ss Innovations International's annual revenue for Dec 31, 2024 was $20.65 million, a 251.46% increase from 2023.
Ss Innovations International's annual revenue for 2023 was $5.88 million, a 309.1% increase from 2022.
Ss Innovations International's annual revenue for 2022 was $1.44 million, a Infinity% increase from 2021.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.